SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $966,000 | -55.1% | 77,049 | -44.1% | 0.01% | -53.3% |
| Q4 2020 | $2,150,000 | +76.5% | 137,782 | +6.9% | 0.02% | +87.5% |
| Q3 2020 | $1,218,000 | -8.6% | 128,882 | -13.3% | 0.01% | -27.3% |
| Q2 2020 | $1,332,000 | +47.7% | 148,582 | +4.9% | 0.01% | +37.5% |
| Q1 2020 | $902,000 | -6.5% | 141,682 | +22.9% | 0.01% | +14.3% |
| Q4 2019 | $965,000 | +0.4% | 115,282 | +8.6% | 0.01% | +16.7% |
| Q3 2019 | $961,000 | -21.3% | 106,182 | -6.4% | 0.01% | -25.0% |
| Q2 2019 | $1,221,000 | +214.7% | 113,382 | +178.9% | 0.01% | +166.7% |
| Q1 2019 | $388,000 | -14.2% | 40,649 | +3.3% | 0.00% | -25.0% |
| Q4 2018 | $452,000 | -38.7% | 39,349 | -9.5% | 0.00% | -33.3% |
| Q3 2018 | $737,000 | +54.2% | 43,500 | +29.1% | 0.01% | +100.0% |
| Q2 2018 | $478,000 | -25.3% | 33,700 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $640,000 | – | 33,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
| Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
| Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
| Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
| State of Wyoming | 92,360 | $55,398 | 0.01% |
| ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
| Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |